IL10 and COVID-19: On the other hand, the increased plasma levels of some pro-inflammatory cytokines such as IP-10, MIP-1α, G-CSF, and IL-10 could suggest a more immunomodulatory effect of MSC rather than immunosuppression in patients with ARDS caused COVID-19.